The AirCurve 11 ASV is an adaptive servo-ventilation (ASV) device engineered to treat patients with central sleep apnea (CSA), obstructive sleep apnea (OSA), mixed apneas, and periodic breathing. As one of the most clinically studied ASV therapies available, it uses advanced algorithms that adapt to each patient’s unique breathing patterns, stabilizing ventilation for more comfortable and natural breathing throughout the night.

Built on the new Air11 platform, the AirCurve 11 ASV combines proven therapy performance with tools to improve comfort, adherence, and outcomes. With intuitive setup, personalized coaching, and remote monitoring features, it helps both patients and providers stay connected and engaged in the therapy journey. Research has shown that patients with complex sleep apnea achieved nearly a 90% reduction in apnea-hypopnea index (AHI) with ASV therapy—significantly higher than results seen with standard CPAP treatment.